{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T14:14:16Z","timestamp":1762179256537,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ijtb.2024.03.001","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T03:53:31Z","timestamp":1710129211000},"page":"233-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Empowering care: Unleashing pharmaceutical care to confront MDR-TB transmission risks-A prospective interventional study"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8340-1809","authenticated-orcid":false,"given":"Vishwa Rajakumar","family":"Byakod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madiwalayya Shivakantayya","family":"Ganachari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijtb.2024.03.001_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061836","article-title":"Rsk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study","volume":"13","author":"Admassu","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijtb.2024.03.001_bib2","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijid.2022.03.026","article-title":"Drug resistant TB\u2013latest developments in epidemiology, diagnostics and management","volume":"124","author":"Tiberi","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.ijtb.2024.03.001_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tube.2012.02.009","article-title":"The unsurprising story of MDR-TB resistance in India","volume":"92","author":"Babu","year":"2012","journal-title":"Tuberculosis"},{"issue":"6","key":"10.1016\/j.ijtb.2024.03.001_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270003","article-title":"Risk factors for multidrug-resistant tuberculosis: a worldwide systematic review and meta-analysis","volume":"17","author":"Xi","year":"2022","journal-title":"PLoS One"},{"year":"2023","series-title":"Prevalence of Multidrug-Resistant Tuberculosis (MDR-TB) in India: A Mini Systematic Review and Meta-Analysis (2016\u20132022)","author":"Atre","key":"10.1016\/j.ijtb.2024.03.001_bib4"},{"issue":"1","key":"10.1016\/j.ijtb.2024.03.001_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-3167-9","article-title":"Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia","volume":"18","author":"Demile","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ijtb.2024.03.001_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4314\/ahs.v15i2.9","article-title":"Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State","volume":"15","author":"Mulu","year":"2015","journal-title":"Afr Health Sci"},{"issue":"1","key":"10.1016\/j.ijtb.2024.03.001_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/0019-557X.82536","article-title":"Risk factors associated with MDR-TB at the onset of therapy among new cases registered with the RNTCP in Mumbai, India","volume":"55","author":"Atre","year":"2011","journal-title":"Indian J Publ Health"},{"key":"10.1016\/j.ijtb.2024.03.001_bib11","first-page":"1270","article-title":"Assessment of adverse drug events, their risk factors, and management among patients treated for multidrug-resistant TB: a prospective cohort study from Pakistan","author":"Khan","year":"2022","journal-title":"Front Pharmacol"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570724000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570724000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:25:26Z","timestamp":1762176326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570724000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0019570724000325"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2024.03.001","relation":{},"ISSN":["0019-5707"],"issn-type":[{"type":"print","value":"0019-5707"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empowering care: Unleashing pharmaceutical care to confront MDR-TB transmission risks-A prospective interventional study","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2024.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}